Saša Anžej Doma
11:20 am
-
11:30 am
Exhibition Hall
Relapsed/refractory AML patients: Therapeutic options
For patients with relapsed or refractory acute myeloid leukemia (AML), treatment can be more challenging due to the resistance of the disease to previous therapies. However, there are several therapeutic options that can be considered to manage relapsed or refractory AML...
12:00 pm
-
12:15 pm
Exhibition Hall
Panel discussion /All speakers
Panel discussion /All speakers for EET Session 2: Acute myeloid leukemia - Therapies